Vital Opportunities for Biosensors
The presentation, Vital Opportunties for Biosensors, will highlight key technology developments, applications, industry transactions and investment activities, growth markets and market opportunties for biosensors. Technology developments will include advancements/innovations in key biosensing technologies such as nanobiosensors, magnetic-based biosensors, graphene biosensors. MEMS biosensors, optical biosensors, electrochemical biosensors, ingestible biosensors, multiparameter biosensors, organ-on-a-chip. Key markets/applications to be addressed include point of care and home diagnostics, wearables, environmental monitoring, food monitoring, defense and security, implantable applications, automotive biometric sensors for detecting a driver’s behavioral attributes, drug screening and delivery, non-invasive glucose monitoring. Key focus areas for biosensor research will be highlighted; along with challenges in the biosensor arena, such achieving devices that provide simple fabrication, high sensitivity and specificity as well as a rapid response, miniaturization, low cost operation and ease of use.
Principal Analyst at Frost & Sullivan
Peter Adrian is a Principal Analyst at Frost & Sullivan, a consulting and market research firm. Mr Adrian, who is based in California, has been researching sensor markets and technologies for over 30 years. Mr. Adrian has closely tracked, reported on, and analyzed key developments in and opportunities for biosensors in diverse areas including miniaturized and wearable biosensors and biosensors for that replace cumbersome lab-type instruments for healthcare and other expanding applications.
